Careers

Diversity

With 18 offices, from New York to Los Angeles and Seattle to Orlando, we live and work in communities all over the U.S., collaborating across locations, disciplines and even borders. Our experienced, highly ranked lawyers serve businesses wherever they are and wherever they want to go.

Offices

About Us

Pages

Professionals

Thought leadership: blogs, podcasts, videos, publications, events and news

Insights

Services

Pro Bono

Am Law 100 firm with practices in Business, Digital Assets and Data Management, Intellectual Property, Labor & Employment, Litigation and Tax.

Home | BakerHostetler

Kenneth Little Co-Authors Chapter for Estate Planning for Retirement Benefits, 2025 Edition

Adapting to Private Practice: From ATF Director to BigLaw (<em>Law360</em>)

Alexander Reid Comments on Survival of Climate-Focused Nonprofits in Bloomberg.com Article

Brian McEvoy Co-chairs, Speaks; Jennifer Solari, Ryan Mayo Speak at ABA Southeastern White Collar Crime Institute

core/heading

The DOJ and HHS announce a strengthened partnership through a new False Claims Act Working Group, aimed at ramping up health care fraud investigations.

core/list-item

The new False Claims Act Work Group will prioritize areas including Medicare Advantage fraud, improper pricing arrangements with pharmaceutical drugs, kickback schemes, barriers to patient care access, and unnecessary utilization of Medicare services and products.

core/list

In a joint announcement, the U.S. Department of Justice (DOJ) and the U.S. Department of Health and Human Services (HHS) unveiled the formation of the new DOJ-HHS False Claims Act Working Group (Working Group) – a strategic enforcement partnership aimed at ramping up investigations and prosecutions of healthcare fraud under the False Claims Act (FCA). This announcement comes days after the DOJ’s announcement of their <a href="https://www.bakerlaw.com/insights/doj-announces-record-breaking-national-health-care-fraud-takedown-against-324-defendants-with-over-14-6-billion-in-alleged-fraud/">largest-ever National Health Care Fraud Takedown</a>.

core/paragraph

The Working Group brings together senior officials from DOJ’s Civil Division, U.S. attorneys’ offices, the HHS Office of General Counsel, the HHS Office of Inspector General and the Centers for Medicare &amp; Medicaid Services Center for Program Integrity.

The initiative underscores the DOJ’s continued focus on prioritizing healthcare fraud and abuse enforcement. The Working Group will focus on priority enforcement areas, including:

Improper drug, device and biologic pricing arrangements, including rebates, service fees and false price reporting

Barriers to patient access to care, including violations of network adequacy requirements

Kickback schemes involving drugs, devices, durable medical equipment and other products paid for by federal healthcare programs

Materially defective medical devices impacting patient safety

Manipulation of electronic health records systems to promote the unnecessary utilization of Medicare services and products

As part of its mission, the Working Group will expedite investigations, increase data-sharing between agencies and use advanced data analytics and enhanced data mining to identify fraudulent schemes. It will also coordinate decisions on payment suspensions under HHS regulations and DOJ motions to dismiss meritless qui tam suits under 31 U.S.C. § 3730(c)(2)(A). Importantly, the Working Group encourages whistleblowers and companies to report suspected FCA violations. This renewed interagency coordination reflects a broader trend toward proactive, data-driven FCA enforcement in the healthcare sector and signals increased scrutiny of providers, manufacturers and payors operating in federally funded healthcare programs.

DOJ and HHS Launch New False Claims Act Working Group to Target Healthcare Fraud

Featured Insights

Related Services

Featured Insights